Header Logo

Connection

Jeremy Luban to Molecular Sequence Data

This is a "connection" page, showing publications Jeremy Luban has written about Molecular Sequence Data.
Connection Strength

0.894
  1. Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Gr?tter C, Martinetti G, Mazzucchelli L, Gr?tter M, Manz MG, Luban J. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest. 2009 Oct; 119(10):3035-47.
    View in: PubMed
    Score: 0.065
  2. Sebastian S, Gr?tter C, Strambio de Castillia C, Pertel T, Olivari S, Gr?tter MG, Luban J. An invariant surface patch on the TRIM5alpha PRYSPRY domain is required for retroviral restriction but dispensable for capsid binding. J Virol. 2009 Apr; 83(7):3365-73.
    View in: PubMed
    Score: 0.062
  3. Gurer C, Berthoux L, Luban J. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. J Virol. 2005 Jan; 79(2):910-7.
    View in: PubMed
    Score: 0.047
  4. Sokolskaja E, Sayah DM, Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol. 2004 Dec; 78(23):12800-8.
    View in: PubMed
    Score: 0.046
  5. Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 2004 Jul 29; 430(6999):569-73.
    View in: PubMed
    Score: 0.045
  6. Cimarelli A, Luban J. Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation. J Virol. 2001 Aug; 75(15):7193-7.
    View in: PubMed
    Score: 0.037
  7. Colgan J, Asmal M, Luban J. Isolation, characterization and targeted disruption of mouse ppia: cyclophilin A is not essential for mammalian cell viability. Genomics. 2000 Sep 01; 68(2):167-78.
    View in: PubMed
    Score: 0.035
  8. Cimarelli A, Luban J. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues. J Virol. 2000 Aug; 74(15):6734-40.
    View in: PubMed
    Score: 0.034
  9. Cimarelli A, Sandin S, H?glund S, Luban J. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. J Virol. 2000 May; 74(9):4273-83.
    View in: PubMed
    Score: 0.034
  10. Cimarelli A, Sandin S, H?glund S, Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol. 2000 Apr; 74(7):3046-57.
    View in: PubMed
    Score: 0.034
  11. Cimarelli A, Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol. 1999 Jul; 73(7):5388-401.
    View in: PubMed
    Score: 0.032
  12. Yin L, Boussard S, Allan J, Luban J. The HIV type 1 replication block in nonhuman primates is not explained by differences in cyclophilin A primary structure. AIDS Res Hum Retroviruses. 1998 Jan 01; 14(1):95-7.
    View in: PubMed
    Score: 0.029
  13. Braaten D, Ansari H, Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J Virol. 1997 Mar; 71(3):2107-13.
    View in: PubMed
    Score: 0.027
  14. Braaten D, Aberham C, Franke EK, Yin L, Phares W, Luban J. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A. J Virol. 1996 Aug; 70(8):5170-6.
    View in: PubMed
    Score: 0.026
  15. Braaten D, Franke EK, Luban J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J Virol. 1996 Jul; 70(7):4220-7.
    View in: PubMed
    Score: 0.026
  16. Colgan J, Yuan HE, Franke EK, Luban J. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J Virol. 1996 Jul; 70(7):4299-310.
    View in: PubMed
    Score: 0.026
  17. Braaten D, Franke EK, Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol. 1996 Jun; 70(6):3551-60.
    View in: PubMed
    Score: 0.026
  18. Re F, Braaten D, Franke EK, Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol. 1995 Nov; 69(11):6859-64.
    View in: PubMed
    Score: 0.025
  19. Bilbao A, Zhang Y, Varesio E, Luban J, Strambio-De-Castillia C, Lisacek F, Hopfgartner G. Ranking Fragment Ions Based on Outlier Detection for Improved Label-Free Quantification in Data-Independent Acquisition LC-MS/MS. J Proteome Res. 2015 Nov 06; 14(11):4581-93.
    View in: PubMed
    Score: 0.025
  20. Zhang Y, Bilbao A, Bruderer T, Luban J, Strambio-De-Castillia C, Lisacek F, Hopfgartner G, Varesio E. The Use of Variable Q1 Isolation Windows Improves Selectivity in LC-SWATH-MS Acquisition. J Proteome Res. 2015 Oct 02; 14(10):4359-71.
    View in: PubMed
    Score: 0.024
  21. Franke EK, Yuan HE, Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 1994 Nov 24; 372(6504):359-62.
    View in: PubMed
    Score: 0.023
  22. Franke EK, Yuan HE, Bossolt KL, Goff SP, Luban J. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J Virol. 1994 Aug; 68(8):5300-5.
    View in: PubMed
    Score: 0.023
  23. Luban J, Goff SP. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. J Virol. 1994 Jun; 68(6):3784-93.
    View in: PubMed
    Score: 0.022
  24. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 1993 Jun 18; 73(6):1067-78.
    View in: PubMed
    Score: 0.021
  25. Luban J, Lee C, Goff SP. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J Virol. 1993 Jun; 67(6):3630-4.
    View in: PubMed
    Score: 0.021
  26. Miyamoto T, Nakayama EE, Yokoyama M, Ibe S, Takehara S, Kono K, Yokomaku Y, Pizzato M, Luban J, Sugiura W, Sato H, Shioda T. The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5a. PLoS One. 2012; 7(10):e47757.
    View in: PubMed
    Score: 0.020
  27. Luban J, Goff SP. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J Virol. 1991 Jun; 65(6):3203-12.
    View in: PubMed
    Score: 0.018
  28. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med. 2003 Sep; 9(9):1138-43.
    View in: PubMed
    Score: 0.011
  29. Zander K, Sherman MP, Tessmer U, Bruns K, Wray V, Prechtel AT, Schubert E, Henklein P, Luban J, Neidleman J, Greene WC, Schubert U. Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J Biol Chem. 2003 Oct 31; 278(44):43202-13.
    View in: PubMed
    Score: 0.011
  30. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol. 1995 Feb; 69(2):642-50.
    View in: PubMed
    Score: 0.006
  31. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 1994 Oct 07; 79(1):119-30.
    View in: PubMed
    Score: 0.006
  32. Berkowitz RD, Luban J, Goff SP. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J Virol. 1993 Dec; 67(12):7190-200.
    View in: PubMed
    Score: 0.005
  33. Dorfman T, Luban J, Goff SP, Haseltine WA, G?ttlinger HG. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J Virol. 1993 Oct; 67(10):6159-69.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.